Xanomeline tartrate

Xanomeline tartrate is a muscarinic acetylcholine receptor agonist with functional selectivity mainly for the M1 and M4 muscarinic receptors. It acts by stimulating these receptors in the central nervous system, leading to cognitive enhancement and antipsychotic-like effects. Because of its M1 receptor agonism, it has been investigated for treating cognitive decline in Alzheimer’s disease and schizophrenia. Xanomeline exhibits strong and persistent binding to muscarinic receptors, which prolongs its effects even after the drug is removed. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Xanomeline L-tartrate and Xanomeline hydrogen tartrate. Its PubChem CID is 71456.

CAS No 152854-19-8
Molecular Formula C18H29N3O7S
Molecular Weight 431.50 g/mol
Synonyms (2R,3R)-2,3-dihydroxybutanedioic acid;3-hexoxy-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazole

Frequently Asked Questions